Related by context. All words. (Click for frequent words.) 74 oophorectomy 72 salpingo oophorectomy 70 vaginal hysterectomy 70 androgen ablation 70 endometrial carcinoma 70 contralateral breast 69 ovariectomy 69 pelvic lymphadenectomy 69 orchiectomy 68 advanced adenoma 68 prophylactic mastectomies 68 axillary node 68 ALND 68 adrenalectomy 68 undergoing radical prostatectomy 68 adjuvant radiotherapy 68 orchidectomy 67 endometrial hyperplasia 67 lymph node removal 67 precancerous cervical 67 invasive carcinoma 67 prophylactic mastectomy 67 atypical hyperplasia 67 postoperative mortality 67 androgen deprivation 66 cystectomy 66 ductal carcinomas 66 undergone hysterectomy 66 gastrectomy 66 parathyroidectomy 66 abdominal hysterectomy 66 thyroid nodules 66 β blockers 66 advanced adenomas 66 locoregional recurrence 66 fibroids endometriosis 66 BRCA1 mutation carriers 66 metachronous 66 radical nephrectomy 66 perioperative complications 66 nonmelanoma skin cancers 66 lobular carcinoma 65 Radical prostatectomy 65 total thyroidectomy 65 postoperative morbidity 65 R0 resection 65 radioiodine therapy 65 androgen suppression 65 axillary lymph node dissection 65 hip BMD 65 Adjuvant chemotherapy 65 prophylactic oophorectomy 65 polyp recurrence 65 lobular cancer 65 extrapleural pneumonectomy 65 leiomyomas 65 prostate cancer CaP 65 thromboembolisms 65 hormone receptor negative 65 patients undergoing CABG 65 carotid stenosis 65 laparoscopically assisted 65 recurrent VTE 65 SLNB 65 varicocele 65 bowel resection 65 EBRT 65 adenoidectomy 65 postoperative atrial fibrillation 65 liver resection 65 preoperative chemotherapy 65 perioperative morbidity 65 perioperatively 65 undergoing hysterectomy 65 partial nephrectomy 64 operable breast cancer 64 ductal breast cancer 64 colorectal adenoma 64 BRCA mutation carriers 64 postoperative complication 64 prostate carcinoma 64 myomas 64 Surgical excision 64 urothelial cancer 64 axillary node dissection 64 breast endometrial 64 sentinel lymph node biopsy 64 urothelial carcinoma 64 liver metastasis 64 nodal metastases 64 corticosteroid therapy 64 NMIBC 64 testosterone supplementation 64 pancreatic resection 64 contralateral breast cancer 64 histologically confirmed 64 debulking surgery 64 pneumonectomy 64 risk reducing salpingo 64 total abdominal hysterectomy 64 endometriosis ovarian cysts 64 ovulation induction 64 nephron sparing surgery 64 lung metastasis 64 singleton pregnancy 64 beta blocker therapy 64 postoperative AF 64 nonfasting triglyceride levels 64 pCR 64 aromatase inhibitor therapy 64 endometrial cancers 64 abnormal Pap smears 64 perioperative mortality 64 symptomatic fibroids 64 bilateral orchiectomy 64 distal colon cancer 64 nodal metastasis 64 HER2 positive cancers 64 postoperative pulmonary 64 hepatectomy 63 hormone therapy estrogen 63 esophagectomy 63 Ovary removal 63 LV dysfunction 63 Postoperative complications 63 thyroidectomy 63 meniscectomy 63 ovarian carcinoma 63 lymph node dissection 63 bilateral prophylactic mastectomy 63 radical retropubic prostatectomy 63 colorectal adenomas 63 axillary dissection 63 CDI recurrence 63 repigmentation 63 underwent resection 63 TURP 63 sacrocolpopexy 63 axillary nodes 63 prostate TURP 63 nephrectomy 63 Postmenopausal 63 reoperations 63 radical prostatectomy RP 63 peritoneal carcinomatosis 63 perimenopausal women 63 tubal reversal 63 cranial irradiation 63 intraoperative complications 63 colon rectal 63 nephrectomies 63 colon resection 63 cytoreductive surgery 63 fibroma 63 IM progesterone 63 breast carcinoma 63 upper endoscopy 63 tibolone 63 PCa 63 % CI #.#-#.# [008] 63 CIN3 63 postoperative chemotherapy 63 GnRH agonists 63 transurethral resection 63 extracapsular extension 62 colorectal carcinoma 62 recurrent ovarian 62 PSA nadir 62 adjuvant radiation 62 lumbar disk herniation 62 Heavy menstrual bleeding 62 parous women 62 postoperative radiotherapy 62 detrusor overactivity 62 postoperative infection 62 pancreatic lung 62 gallstone disease 62 situ LCIS 62 PSADT 62 CVD mortality 62 adenoma recurrence 62 serum testosterone levels 62 pelvic prolapse 62 peritoneal cancer 62 clinically localized prostate 62 colectomy 62 gastric cardia 62 distant metastases 62 RYGB 62 adnexal mass 62 carotid atherosclerosis 62 preventive mastectomies 62 coronary calcification 62 retrograde ejaculation 62 recurrent UTI 62 BRCA1 mutations 62 invasive ductal 62 chorioamnionitis 62 coronary arteriography 62 biochemical relapse 62 axillary lymph nodes 62 abnormal mammograms 62 atherosclerotic renal artery stenosis 62 adenomatous polyps 62 surgical revascularization 62 azoospermia 62 chronic prostatitis 62 intravesical therapy 62 biochemical recurrence 62 pT3 62 lymphadenectomy 62 intraductal 62 metaplasia 62 TURBT 62 testicular tumors 62 H. pylori eradication 62 pancreatic adenocarcinoma 62 sentinel node biopsy 62 prostate adenocarcinoma 62 benign noncancerous 62 thromboembolic disease 62 graft occlusion 62 adenomatous 62 nonpregnant women 62 androgen suppression therapy 62 colorectal tumors 62 percutaneous interventions 62 DHEA supplementation 62 antiangiogenic therapy 62 enucleation 62 CI #.#-#.# [001] 62 Cesarean deliveries 62 femoral neck fracture 62 colorectal polyp 62 Fibroid tumors 62 GnRH agonist 62 atrophic gastritis 62 Coronary artery bypass graft 62 LNG IUS 62 noncardiac 62 Tubal ligation 62 cholecystectomy 62 malabsorptive 62 reimplantation 62 pathologic fractures 62 adenoma 62 elevated CRP 62 osteosarcomas 62 esophageal gastric 61 oral antidiabetic medication 61 testicular cancers 61 haemorrhagic stroke 61 salivary flow 61 contralateral prophylactic mastectomy 61 thymectomy 61 spontaneous bacterial peritonitis 61 estrogen deficiency 61 HER2 expression 61 Thal Dex 61 noncancer 61 hMG 61 cytoreduction 61 pulmonary metastasis 61 nulliparous women 61 carcinoid tumor 61 intestinal polyps 61 LAGB 61 chlamydial infection 61 lung resections 61 BRCA2 mutation carriers 61 thromboembolic 61 undergone radical prostatectomy 61 nondiabetic patients 61 ovarian hormones 61 colorectal neoplasms 61 impair fertility 61 ovulatory cycles 61 thoracoscopic lobectomy 61 resections 61 subclinical hypothyroidism 61 biliary obstruction 61 oesophageal adenocarcinoma 61 retransplantation 61 neoplasias 61 vertebral fracture 61 primary hyperparathyroidism 61 atypia 61 skin sparing mastectomy 61 vaginal hysterectomies 61 noncardiovascular mortality 61 Gall bladder 61 cervical lesions 61 renal tumors 61 premenopausal breast cancer 61 basal cell cancers 61 intima media thickness 61 osteopenic 61 node dissection 61 RALP 61 recurrent miscarriage 61 glycated hemoglobin levels 61 tumor resection 61 LYSTEDA 61 serum uric acid 61 oophorectomy removal 61 fetal malformations 61 radical cystectomy 61 cranial radiation 61 abnormal Pap smear 61 epithelial ovarian 61 venous blood clots 61 transfusion syndrome 61 nonischemic 61 intact parathyroid hormone 61 chemoradiotherapy 61 RYGB surgery 61 Cystectomy 61 cerebral angiography 61 benign breast 61 bladder cancers 61 orchitis 61 chronic rhinosinusitis 61 asymptomatic carotid stenosis 61 underwent radical prostatectomy 61 serum PSA 61 revascularizations 61 adenoma detection 61 advanced neoplasia 61 mutated K ras 61 SIADH 61 antireflux surgery 61 uterine tumors 61 postoperative infections 61 neutropenic patients 61 mL/min/#.# m 2 61 fragility fracture 61 mIU L 61 undergo mastectomy 61 precancerous polyp 61 catheter angiography 61 transrectal ultrasound guided 61 benign nodules 61 ASCUS 61 neoplastic lesions 61 thyroid dysfunction 61 arteriography 61 spinal metastases 61 Contralateral 61 underwent radical cystectomy 61 lipid lowering therapy 60 serum creatinine levels 60 carotid IMT 60 HER2 amplified 60 P = .# 60 bladder prostate 60 HoLEP 60 corticosteroid induced 60 BRCA gene mutations 60 noninvasive outpatient 60 thyroid carcinoma 60 subclinical hyperthyroidism 60 carotid artery stenting CAS 60 % CI #.#-#.# [007] 60 sleeve lobectomy 60 retroperitoneal 60 HBeAg seroconversion 60 Erythropoietic therapies may 60 BRCA2 gene mutation 60 endocrine therapies 60 secondary amenorrhea 60 pulmonary metastases 60 neoadjuvant 60 revascularization procedure 60 revascularization procedures 60 ovarian cervical 60 recurrent metastatic 60 HNSCC 60 Statin therapy 60 postmenopausal hormone replacement 60 hyperparathyroidism 60 thrombocytopenic 60 cytoreductive nephrectomy 60 lung resection 60 hip resurfacing arthroplasty 60 micrometastases 60 polycystic ovary syndrome PCOS 60 Endometrial 60 lichen planus 60 anticoagulants blood thinners 60 fibrinolysis 60 renal cell carcinomas 60 morphometric vertebral fractures 60 postoperative complications 60 ALT elevation 60 mammographic density 60 gestational hypertension 60 screening colonoscopy 60 premenopausal women 60 Uterine fibroids 60 uterine cancers 60 selenium supplementation 60 colorectum 60 seminal vesicle invasion 60 benign prostatic hypertrophy 60 Coronary artery bypass 60 neoadjuvant chemotherapy 60 invasive carcinomas 60 estrogen progestin therapy 60 subtrochanteric 60 noncardiac surgery 60 CI #.#-#.# [002] 60 lobular breast cancer 60 autologous transplants 60 tumor recurrence 60 anthracycline taxane 60 histologic subtype 60 prostatectomy 60 histologically proven 60 epididymitis 60 gastroesophageal junction 60 malignant neoplasm 60 AVODART 60 neoadjuvant therapy 60 serous ovarian cancer 60 PLX STROKE targeting 60 esophageal resection 60 nonsurgical treatments 60 radiochemotherapy 60 endometrial biopsy 60 de ath 60 menstrual abnormalities 60 mammographic breast density 60 IV bisphosphonates 60 intravenous bisphosphonates 60 sentinel node 60 biliary tract cancers 60 transurethral 60 metastatic lymph nodes 60 antibiotic prophylaxis 60 HER2 positive tumors 60 papillary carcinoma 60 proximal colon 60 flutamide 60 malignant lesions 60 lumbar spine BMD 60 relapsed MM 60 distal colon 60 polycystic ovaries 60 gallstone formation 60 ovarian stimulation 60 pancreatectomy 60 chronic periodontitis 60 periprocedural 60 adenotonsillectomy 60 ICD implantation 60 lymphocytosis 60 surgical debulking 60 Mitomycin C 60 MetS 60 cerebral vasospasm 60 node metastases 60 cystoscopic 60 hamartoma 60 ductal cancer 60 Surgical resection 60 VCUG 60 subfertility 60 deep venous thromboses 60 immunosuppressive regimen 60 normotensive 60 Malignant tumors 60 preventive mastectomy 60 hormonal therapy 60 hypogonadal men 60 thromboembolic events 60 BRCA2 mutations 60 neurodevelopmental impairment 60 carotid revascularization 60 neurodevelopmental outcomes 60 intestinal metaplasia 60 coronary blockages 60 laparoscopic hysterectomy 60 amenorrhoea 60 nonmetastatic 60 incidentalomas 60 anovulation 60 Parathyroid hormone 60 reinterventions 60 hormonal treatments 60 Caesarean deliveries 60 chemoradiation therapy 60 Calcium intake 60 serum selenium 60 sympathectomy 60 ovarian uterine 60 thromboembolism 60 pelvic lymph node dissection 60 symptomatic hyponatremia 60 LUTS 60 BRCA2 carriers 60 refractory ischemia 60 irregular menstrual cycles 60 BRCA mutations 60 anovulatory 60 pancreas esophagus 60 uterus fallopian tubes 60 abnormal vaginal bleeding 60 premalignant 60 donor nephrectomy 60 nonmelanoma skin cancer 60 Myocardial infarction 60 treated nonsurgically 60 stratifying patients 60 metastatic lung cancer 60 % CI #.#-#.# [003] 60 systolic dysfunction 60 recanalization 60 cervical lymph nodes 59 histological subtype 59 premenopausal 59 confidence interval #.#-#.# 59 heterotaxy 59 transarterial 59 hematopoietic cancers 59 oropharyngeal cancer 59 abnormal Pap test 59 CMV infections 59 total knee arthroplasties 59 thyrotropin levels 59 HGPIN 59 multivariate adjustment 59 recurrent glioblastoma multiforme 59 pulmonary resection 59 sarcomatoid 59 bilateral salpingo oophorectomy 59 elective PCI 59 hormonal stimulation 59 breast asymmetry 59 neurodevelopmental outcome 59 HbA1C levels 59 cisplatin resistant 59 artery embolization 59 Endometrial ablation 59 #.#/#.# mmHg [001] 59 bowel cancers 59 abnormal uterine bleeding 59 revascularized 59 reinfarction 59 dysfunctional voiding 59 nonobese 59 extracapsular 59 hyperplastic polyps 59 pyelonephritis 59 aortic root replacement 59 postmenopausal hormones 59 postintervention 59 serum estradiol 59 uterine fibroid tumors 59 anovulatory infertility 59 Colon polyps 59 testicular germ cell 59 posttraumatic arthritis 59 fallopian tube cancers 59 unresectable tumors 59 beta carotene supplementation 59 loop diuretics 59 fibrocystic disease 59 complete cytogenetic response 59 medically inoperable 59 cutaneous melanoma 59 elevated LDH 59 femoral neck BMD 59 bacteriuria 59 Androgen deprivation therapy 59 patients undergoing noncardiac 59 parathyroid 59 antimicrobial prophylaxis 59 thyroid hormone levels 59 hepatic resection 59 progestin therapy 59 invasive lobular 59 vasectomy reversal 59 surgically induced 59 pT2 59 recurrent venous thromboembolism 59 precancerous condition 59 breast uterine 59 amenorrhea 59 prior nephrectomy 59 precursor lesions 59 pelvic radiotherapy 59 T1c 59 multivessel disease 59 OPCAB 59 nephrogenic 59 CR nPR 59 atypical ductal hyperplasia 59 left ventricular dysfunction 59 paroxysmal AF 59 fundoplication 59 incomplete revascularization 59 Carotid endarterectomy 59 progesterone receptor negative 59 CYP#D# inhibitor 59 ovarian hyperstimulation 59 curative resection 59 pacemaker implantation 59 cancerous enlargement 59 undergo radical prostatectomy 59 conventional angiography 59 laparoscopic adjustable gastric banding 59 hormone receptor status 59 hepatic metastases 59 lipomas 59 FGFR2 gene 59 nonalcoholic steatohepatitis NASH 59 adjuvant hormonal therapy 59 nonoperative 59 seminomas 59 urethral stricture 59 anal cancers 59 preeclamptic 59 endosonography 59 ventricular tachyarrhythmia 59 conjugated equine estrogen 59 Operative mortality 59 Soy isoflavones 59 tamoxifen Nolvadex ® 59 CHD mortality 59 angiographically 59 coronary revascularization procedures 59 denervation 59 Coronary artery bypass grafting 59 prednisone prednisolone 59 carotid artery blockage 59 colonoscopic 59 systemic corticosteroid 59 polyp detection 59 laproscopic procedure 59 CIN2 + 59 varicoceles 59 venous thrombosis 59 premalignant lesions 59 Chlamydia trachomatis infection 59 antiplatelet medication 59 nonvertebral fractures 59 spontaneous preterm delivery 59 arterial calcification 59 pulmonary artery banding 59 Complication rates 59 variceal bleeding 59 LHRH receptor positive 59 upper gastrointestinal endoscopy 59 osteoarthritic 59 paclitaxel eluting stents 59 echocardiographic parameters 59 postoperative bleeding 59 undergone hysterectomies 59 carotid surgery 59 rebleeding 59 nerve sparing 59 vulvar intraepithelial neoplasia 59 transabdominal 59 truncal 59 ovarian hyperstimulation syndrome 59 ankle arthrodesis 59 treat menorrhagia 59 aortic atherosclerosis 59 preventative mastectomy 59 albumin excretion rate 59 ipsilateral 59 epidural analgesia 59 #.#ng/ml 59 lymph node involvement 59 core needle biopsies 59 biliopancreatic diversion 59 Lumpectomy 59 antithrombotic therapy 59 specific antigen PSA 59 skeletal metastases 59 parathyroid carcinoma 59 hydronephrosis 59 sentinel nodes 59 basal cell carcinoma BCC 59 breast conserving 59 metastatic malignant 59 lung esophageal 59 hemoglobin A1c levels 59 CP CPPS 59 postmenopausal breast cancer 59 clinically insignificant 59 fibrocystic changes 59 serum thyroglobulin 59 silent ischemia 59 artery bypass 59 transplantation HCT 59 ovarian malignancy 59 clodronate 59 Computerized tomography 59 Combination therapy 59 mammary tumors 59 lymph node metastasis 59 revascularisation 59 gastric adenocarcinoma 59 endarterectomy 59 OAB symptoms 59 nonoperative treatment 59 ovulatory 59 malignant polyps 59 core needle biopsy 59 external beam radiotherapy 59 fibrocystic 59 cervical lymph node 59 benign prostatic hyperplasia enlarged 59 upper gastrointestinal bleeding 59 epithelial ovarian cancer 59 triiodothyronine 59 Papillary 59 Hashimoto thyroiditis 59 microdebrider 59 infective endocarditis 59 cervical carcinoma 59 chemoembolization 59 antiandrogens 59 moderate renal impairment 59 venous thromboembolic events 59 radiotherapy RT 59 GISTs 59 renal biopsy 59 nonmelanoma 59 hypertrophic scars 59 HER2 amplification 59 minimally symptomatic 59 anastomotic leak 59 urine cytology 59 breast abscesses 59 occlusive disease 59 ischemic mitral regurgitation 59 elevated transaminases 59 nonischemic cardiomyopathy 59 pre cancerous polyps 59 needle aspiration 59 PAP smears 59 lobular carcinomas 58 pretransplant 58 preoperative PSA 58 clinically detectable 58 NNT = 58 aortic coarctation 58 preintervention 58 undergo lumpectomy 58 spontaneous preterm birth 58 ejection fractions 58 endogenous estrogen 58 thyrotoxicosis 58 dyspareunia 58 microvascular disease 58 breast cancer recurrences 58 thrombophilia 58 TRUS biopsy 58 basilar 58 malignant prostate 58 myoma 58 metastatic prostate 58 cerebral infarction 58 Hormonal therapy 58 pre eclamptic 58 hormonally sensitive 58 onset diabetes mellitus 58 coinfection 58 transferrin saturation 58 heavy menstrual bleeding 58 PASI scores 58 nonalcoholic steatohepatitis 58 serum phosphate 58 myocardial fibrosis 58 estrogen receptor negative 58 liver transplant recipients 58 HIPEC 58 surgically resectable 58 plus progestin hormone 58 spontaneous regression 58 BENICAR HCT 58 benign uterine 58 Ishak fibrosis score 58 excisional biopsy 58 noncancerous tumors 58 acetabular dysplasia 58 cancerous colon polyps 58 anemia hemoglobin 58 Cardiopulmonary bypass 58 hypertension diabetes mellitus 58 intracranial atherosclerosis 58 knee OA 58 lenalidomide Revlimid R 58 adjuvant therapy 58 CrCl 58 perinatal outcomes 58 Duodenal 58 cilostazol 58 allogeneic HSCT 58 colorectal polyps 58 hypothalamic amenorrhea 58 PRADAXA #mg 58 BRCA deficient 58 egg retrieval 58 MACCE 58 dysmenorrhoea 58 nonobstructive 58 endometrial biopsies 58 Subgroup analyzes 58 chemopreventive agent 58 recurrent UTIs 58 undescended testes 58 obstructive coronary artery 58 oocyte retrieval 58 postoperative delirium 58 oesophageal 58 serum calcium levels 58 lymphomas leukemias 58 elevated triglyceride levels 58 oncological outcomes 58 bladder tumors 58 perianal 58 invasive lobular carcinoma 58 laparoscopic nephrectomy 58 lobectomy 58 poorer prognosis 58 TP# mutations 58 F FDG PET 58 endometrial thickness 58 Leydig cell 58 Prostatitis 58 removed laparoscopically 58 invasive ductal breast cancer 58 postmenopausal hormone 58 nulliparous 58 Androgens 58 EXJADE 58 biliary tract cancer 58 VATS lobectomy 58 myomectomy 58 antioxidant supplementation 58 Burch colposuspension 58 neurologic complications 58 neointimal hyperplasia 58 reinnervation 58 urolithiasis 58 neurologic deficits 58 castrate resistant 58 taxane therapy 58 carotid plaque 58 SLN biopsy 58 Glioblastoma Multiforme GBM 58 mediastinal 58 GIST tumors 58 gross hematuria 58 MGUS 58 resistant hormone refractory 58 arteriovenous fistula 58 severe renal impairment 58 precancerous tumors 58 vasomotor symptoms 58 macrovascular 58 VUR 58 mucosal healing 58 thymoma 58 renal agenesis 58 para aortic 58 thromboprophylaxis 58 microvascular complications 58 percutaneous drainage 58 % CI #.#-#.# [006] 58 cerebral microbleeds 58 radiographic findings 58 EUS FNA 58 surgical biopsies 58 renal artery stenosis 58 sonographically guided 58 vascular insufficiency 58 reflux esophagitis 58 colon adenomas 58 UPPP 58 phytoestrogen intake 58 normal karyotype 58 biopsied breast 58 bronchoalveolar lavage 58 NNRTI resistance 58 Nonsurgical 58 fibrin deposition 58 baseline LDH 58 CC genotype 58 abdominal pelvic 58 glomerular filtration 58 genital lesions 58 Amniocentesis 58 nonfatal MI 58 surgical excision 58 p# mutation 58 hypoperfusion 58 genitourinary tract 58 binary restenosis 58 multiple gestations 58 obese postmenopausal 58 neurologic outcomes 58 myelomeningocele 58 shorter telomere length 58 thrombotic complications 58 underwent brachytherapy 58 bile duct cancers 58 VT VF 58 tamoxifen therapy 58 severe periodontitis 58 serum urate levels 58 metastatic gastric 58 trabeculectomy 58 coronary revascularization 58 grade squamous intraepithelial 58 aromatase inhibitors AIs 58 myeloablative 58 dysglycemia 58 BRCA2 mutation 58 pre menopausal 58 immunosuppressive medications 58 microvascular dysfunction 58 artery stenosis 58 serum lipid levels 58 arterial stiffening 58 diagnostic angiography 58 mucinous 58 tubal 58 adjuvant tamoxifen 58 carotid endarterectomy CEA 58 Stent thrombosis 58 Sentinel node biopsy 58 anal incontinence 58 TNF blocker therapy 58 bowel polyps 58 myocardial infarction MI 58 TKAs 58 perfusion defects 58 hippocampal atrophy 58 pharmacological therapies 58 obstetric complications 58 coronary artery bypass grafts 58 posttransplant 58 leukemia multiple myeloma 58 Liver transplantation 58 HIV HCV coinfected 58 hypercoagulability 58 atypical fractures 58 carotid artery stenosis 58 prospectively stratified 58 thiazide diuretics 58 NSTE ACS 58 adjuvant therapies 58 elevated serum creatinine 58 undergoing coronary angiography 58 invasive biopsy 58 submandibular gland 58 breast reconstructions 58 osteoid 58 keloid scarring 58 symptomatic benign prostatic 58 Menopausal hormone therapy 58 smoldering myeloma 58 computed tomography angiography 58 colon tumors 57 bladder augmentation 57 hypopituitarism 57 nonvascular 57 non resectable metastatic 57 surgical decompression 57 polycystic 57 Mohs micrographic surgery 57 radical prostatectomy 57 Subgroup analysis 57 corifollitropin alfa 57 folate supplementation 57 malignant neoplasms 57 unexplained infertility 57 esophagogastric junction 57 CMV disease 57 amyloid deposition 57 adjuvant chemotherapy 57 glucocorticoid therapy 57 polypectomy 57 postsurgical 57 pg ml 57 lobular involution 57 carotid artery ultrasound 57 hemorrhagic complications 57 polycystic ovarian syndrome PCOS 57 resectable 57 postoperative hemorrhage 57 MMSE scores 57 benign ovarian 57 follicular thyroid cancer 57 thrombo embolic